// App-Quantinova.ai

: Genomic concordance between profiling of circulating tumor DNA (ctDNA) and matched tissue in metastatic urothelial carcinoma.

Researchers

Presenter

  • Gillian Vandekerkhove

Principal Investigators

  • Jean-Michel Lavoie

  • Matti Annala

  • Nora Sundahl

  • Takeshi Sano

  • Werner J. Struss

  • Tilman Todenhfer

  • Piet Ost

  • Kim N. Chi

  • Peter C. Black

  • Bernhard J. Eigl

  • Alexander William Wyatt

Medical Centers

  • Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada

  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada

  • Institute of Biosciences and Medical Technology, Tampere, Finland

  • Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, Ghent, Belgium

  • Department of Radiation Oncology, University Hospital Tubingen, Tuebingen, Germany

  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada

Locations

  • Canada

  • Finland

  • Belgium

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

Disease

  • Advanced Urothelial Carcinoma

  • Bladder Cancer

  • Solid malignancies

Biomarkers

  • Circulating DNA

  • Plasma cell-free DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved